BioProtect

Developer of biodegradable balloon implants designed to protect healthy tissue during radiation therapy for prostate cancer.

Health Tech & Life Sciences
Acquired by Olympus
Acquired Netanya, Israel Founded 2004
Last updated 2026-07-26
Total raised
$62.1M
Last: D Round 2023-09
Stage
Acquired
Founded
2004
Headcount
130
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences

About

BioProtect is an Israeli medical device company that has developed a biodegradable, balloon-shaped implant designed to protect healthy tissue during radiation therapy for prostate cancer patients. The company's product, the BioProtect Balloon Implant System, acts as a spacer to displace healthy tissue from the radiation field. It received FDA approval at the end of 2023 and is commercially available in the US and Europe. BioProtect was acquired by Olympus in May 2026 for $270 million. Its operations are expected to remain in Israel following the acquisition.

Funding history · 10 rounds · $62.1M total

2025-04
G Round Undisclosed
★ Peregrine Ventures
2020-08
F Round $25.0M
★ Accelmed★ Medtronic★ Triventures★ KB Investment★ Almeda Ventures★ Vincent Tchenguiz★ Peregrine Ventures
2017-03
E Round $4.0M
★ BKP Med-Invest★ Xenia Venture Capital
2016-05
D Round $500K
★ EarlyCap★ Rafi Gidron★ Igal Ahouvi★ AJJS Holdings Inc.★ Xenia Venture Capital★ Tevel Global Angels Inc★ Aran Research and Development Ltd.★ Virginia Life Sciences Investments (VLSI)
2014-09
Grant $8K
2012-11
C Round $2.9M
★ Igal Ahouvi★ Rafi Gidron★ AJJS Holdings Inc.★ Xenia Venture Capital★ Tevel Global Angels Inc★ Virginia Life Sciences Investments (VLSI)
2008-05
B Round $990K
★ EarlyCap★ Rafi Gidron★ Igal Ahouvi★ Xenia Venture Capital
2006-01
A Round $700K
★ EarlyCap★ Rafi Gidron★ Igal Ahouvi★ Shlomo Mashiach★ AJJS Holdings Inc.★ Xenia Venture Capital
2004-09
Seed Undisclosed
★ Xenia Venture Capital
Date unknown
H Round $28.0M
★ MVM Life Science PartnersTriventuresKB InvestmentAlmeda VenturesPeregrine VenturesConsensus Business Group (CBG)

Headcount over time

From 28 (2018-09) to 116 (2026-03) · +88 (+314%) · 48 points · source: Finder history + radar grounding
1160 2018-09 2026-03

Q&A

When was BioProtect acquired and by whom?
BioProtect was acquired by Olympus in May 2026 for $270 million.
What is BioProtect's core product?
BioProtect develops a biodegradable, balloon-shaped implant designed to protect healthy tissue during radiation therapy for prostate cancer patients. This product is known as the BioProtect Balloon Implant System.
When did BioProtect receive FDA approval for its product?
BioProtect received FDA approval for its product at the end of 2023.
What was BioProtect's most recent funding round before its acquisition?
BioProtect raised a C Round of $28 million in September 2023, with MVM Partners as a lead investor.
Where is BioProtect's headquarters located?
BioProtect's headquarters is located in Netanya, Israel.
What is the employee count range for BioProtect?
BioProtect has 51-200 employees.
Who are the co-founders of BioProtect?
The co-founders of BioProtect are Dr. Adrian Paz, Shaul Shohat, and Prof. Avi Domb.
What is the total amount of funding BioProtect raised before its acquisition?
BioProtect raised a total of $80 million in funding.

Team · 7

Dr. Adrian Paz
Founder · Co-Founder
Shaul Shohat
Founder · Co-Founder
Prof. Avi Domb
Founder · Co-Founder
Chief Operating Officer
Shahar Shaked
VP Finance & Administration
VP, Clinical Affairs

Sectors & technology

Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B

Highlights

Patents

Tags

cancersurgerybiodegradableoncologyminimally-invasivemedical-devicesdoctorshospitalsmedical-technologiestreatmentspolymersradiologyprostate-cancerradiation-therapyurologyimplants
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitebioprotect.com
LinkedInlinkedin.com/company/439364

Identifiers & details

Legal nameBioProtect Ltd.
Founded2004
Employees (exact)130

Acquisitions & public offerings

Acquired by Olympus 2026-05 $270.0M

Radar intelligence

Patents

EPO19

Publications (Crossref)

Works2

GitHub

Top reposBioProtect-Marine-Planner-UI, BioProtect-Marine-Planner-Server, Engage

Web history (Wayback)

Domainbioprotect.com

Certificate / subdomain footprint

Subdomains8